Does Molina Cover Tirzepatide? Mounjaro, Zepbound, Appeals

Molina Healthcare does cover tirzepatide, but whether your prescription gets paid depends on three things: which brand you’re prescribed, which Molina plan you have, and the state you live in. Mounjaro, prescribed for type 2 diabetes, is generally covered across Molina plans with prior authorization. Zepbound, prescribed for weight loss or obstructive sleep apnea, is a much harder path, and for most Molina Medicaid and Medicare members it isn’t covered at all for weight loss.

Why the Brand on the Prescription Changes Everything

Tirzepatide is the same molecule in both products, but Eli Lilly sells it as Mounjaro for type 2 diabetes and as Zepbound for weight management and obstructive sleep apnea. Insurers categorize them separately. Mounjaro sits under diabetes benefits, which Molina plans cover. Zepbound sits under weight-management benefits, a category many Molina plans exclude by law or by policy.¹

So the first question to ask your prescriber is which brand they wrote the script for, and the second is what diagnosis code they put on it. Those two details decide most of what follows.

Mounjaro for Type 2 Diabetes

Molina formularies list Mounjaro as a covered diabetes medication. The New York Essential Plan formulary effective April 2026 includes “Mounjaro (Tirzepatide)” under diabetes medications with zero cost-sharing for members with a diabetes diagnosis.² Coverage is subject to prior authorization, and Molina may require documentation that you’ve already tried other diabetes medications. In the California Marketplace plan, members with type 2 diabetes must document a trial and inadequate response to all formulary GLP-1 or GLP-1/GIP agents indicated for diabetes before tirzepatide is authorized.³

Tier placement and copays vary. Some Molina plans use a three-tier structure that puts brand-name drugs on Tier 2 or Tier 3; at least one Molina Medicare D-SNP plan uses a single tier with a $0 copay for all covered drugs.⁴ For your exact cost, use Molina’s online formulary search or call the pharmacy number on your member ID card.

Zepbound for Weight Loss

Here the answer splits by plan type.

Medicaid

If you have Molina Medicaid and want Zepbound for weight loss, assume it isn’t covered unless you can confirm otherwise. Federal law lets state Medicaid programs exclude drugs used for weight loss from the Medicaid Drug Rebate Program. As of January 2026, only 13 state Medicaid programs cover GLP-1 drugs for obesity under fee-for-service, and the trend has been shrinking: California, New Hampshire, Pennsylvania, and South Carolina have all dropped coverage.⁵ Molina’s Washington state Medicaid page states that “medications used for weight loss” are not covered.⁶ Even in states that do cover anti-obesity drugs, Molina as the managed care organization may apply tighter restrictions than the state’s fee-for-service rules.⁷

One exception matters: Medicaid’s Early and Periodic Screening, Diagnostic and Treatment benefit requires coverage of medically necessary treatments for members under 21, which can include weight-loss medications when clinically indicated.⁵

Marketplace

Molina’s California Marketplace plan has a published policy that covers Zepbound for morbid obesity, but with strict requirements: a BMI of 40 or higher, or a BMI of 35 or higher with obesity-related conditions such as diabetes, sleep apnea, or hypertension. You also have to complete a three-month formalized weight-management program before authorization and show at least 10% weight loss by week 24 to keep the prescription going.³ Whether other state Marketplace plans offer similar coverage isn’t clear from Molina’s published documents, so check your own plan’s formulary.

Medicare

Federal law prohibits Medicare Part D plans from covering weight-loss drugs, and that prohibition still applies to standard Molina Medicare plans. Starting July 2026, however, the federal government launched the Medicare GLP-1 Bridge, a temporary program that sits outside Part D and lets eligible Medicare beneficiaries get Zepbound or Wegovy for weight loss at a fixed $50 monthly copay. The program is administered centrally, not by Part D sponsors like Molina, and amounts paid through it don’t count toward Part D deductibles or out-of-pocket limits.⁸⁹

To qualify, you must be 18 or older, have Medicare with prescription drug coverage, and meet clinical criteria including minimum BMI thresholds and documented comorbidities such as heart failure, hypertension, or chronic kidney disease. The Bridge is scheduled to run through at least December 2027. A longer-term model called BALANCE, which would have allowed Part D sponsors to opt into direct coverage, has been delayed indefinitely.⁹

Zepbound for Obstructive Sleep Apnea

Zepbound was approved by the FDA in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity. This diagnosis opens a different coverage path. Medicaid programs that exclude weight-loss drugs are still required to cover GLP-1 medications prescribed for other FDA-approved indications, and OSA counts.⁵

No Molina-specific OSA policy for Zepbound appears in available documents. Insurers that have published policies for this indication generally require a sleep study confirming moderate-to-severe OSA (15 or more obstructive respiratory events per hour), a BMI of 30 or higher, and documented lifestyle modification efforts. Initial approvals typically last six months, and renewals depend on measurable improvement.¹⁰

What Prior Authorization Looks Like

Molina requires prior authorization for tirzepatide regardless of indication. Criteria vary by plan, state, and brand, but the recurring elements include:

BMI thresholds. Molina’s Virginia weight-loss authorization form requires a BMI of 30 or higher, or 27 or higher with two or more risk factors such as coronary heart disease, hypertension, dyslipidemia, sleep apnea, or type 2 diabetes. The California Marketplace policy sets a higher bar at BMI 40, or 35 with comorbidities.¹¹³
A documented trial of a non-GLP-1 weight-loss medication before Zepbound is approved.¹¹
Documentation of nutritional counseling and a physical activity program, with a commitment to continue.¹¹
Age 18 or older for weight management.
No concurrent use of another GLP-1 receptor agonist such as Ozempic or Victoza.¹¹

Initial authorizations typically run six months. Renewal requires evidence the drug is working: at least 5% loss of baseline weight under the Virginia weight-loss criteria, or 10% under the California Marketplace morbid obesity policy.¹¹³

If Molina Denies the Prescription

You have the right to appeal. Molina Medicaid plans generally follow a four-step process: an internal Molina appeal, a state administrative hearing, an independent review, and a final decision by a state review judge.¹²

Important details:

You have 60 calendar days from the date on the denial letter to file.
Appeals can go by phone, fax, or mail. Phone appeals on Medicaid plans may need a signed written follow-up.
If your provider certifies that waiting on a standard decision puts your health at risk, you can request an expedited review, decided within 72 hours.¹²
If you were already approved for the medication and want to keep receiving it during the appeal, you must tell Molina within 10 calendar days of the denial letter. You may owe the cost if the appeal fails.¹³
You can request a free copy of your appeal file, medical records, and the specific coverage guidelines Molina used.¹²

Molina Medicare plans use a similar 60-day window but call the first step a redetermination. If the drug is off-formulary, your prescriber must submit a statement explaining why formulary alternatives won’t work for your condition.¹⁴

If Molina Won’t Pay

Eli Lilly offers savings cards that drop Mounjaro or Zepbound to as low as $25 per month for people whose commercial plans cover the drug, or $499 per month for those with commercial insurance that doesn’t. A self-pay KwikPen version of Zepbound starts at $299 per month for the lowest dose.¹⁵¹⁶

The catch for most Molina members: the Lilly savings cards exclude anyone on a government-funded program, including Medicaid, Medicare, Medicare Advantage, TRICARE, and VA programs.¹⁵ Since most Molina members are enrolled in Medicaid or Medicare, that rules out the manufacturer discount.

Medicare beneficiaries with Part D drug coverage who meet the clinical criteria can get Zepbound or Wegovy through the Medicare GLP-1 Bridge program at $50 per month, regardless of their Part D sponsor.⁸

1
Drugs.com. Zepbound vs. Mounjaro Complete Comparison Guide
2
Molina Healthcare. Affinity by Molina Healthcare Essential Plan Formulary
3
Molina Healthcare. Drug and Biologic Coverage Criteria, Policy C28425-A
4
Molina Healthcare. Molina Medicare Complete Care Formulary
5
KFF. Medicaid Coverage of and Spending on GLP-1s
6
Molina Healthcare. Washington Medicaid Drug Formulary
7
JAMA Network. Medicaid Coverage of Antiobesity Medications
8
CMS. Medicare GLP-1 Bridge
9
Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026
10
Oregon P&T Committee. Tirzepatide OSA Prior Authorization Update
11
Molina Healthcare. Weight Loss Service Authorization Form (Virginia)
12
Molina Healthcare. How to Appeal a Denial
13
Molina Healthcare. Molina Healthcare Member Appeal Procedures
14
Molina Healthcare. How to Request Redetermination (Michigan)
15
Eli Lilly. Zepbound Savings
16
Eli Lilly. Mounjaro Savings and Coverage